Debiopharm & BIOASTER join forces to expand research to combat infectious diseases. Debiopharm and BIOASTER  announced having officialized a broad research agreement for the development of diagnostic and management innovation for infectious diseases. This relationship will harness BIOASTER’s scientific and technical expertise, including technology platforms, to support Debiopharm’s breakthrough research...

BIOASTER announces a collaboration with LNC Therapeutics, a leading biotech in the development of innovative microbiome-based therapies, located in Bordeaux, France. The aim of the...